Therapy Areas: Infectious Diseases
Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases
19 November 2019 - - US-based pharmaceutical company Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) and Denmark-based Novo Nordisk A/S have inked an agreement to discover and develop nove...
FDA approves new antibacterial drug Fetroja to treat complicated urinary tract infections
15 November 2019 - The US Food and Drug Administration (FDA) on Thursday authorised the marketing of the antibacterial drug Fetroja (cefiderocol) for treatment of patients 18 years of age or older wit...
Newly Published Research Demonstrates Ability of Hologic's Assay to Detect Mycoplasma Genitalium, "the Silent Epidemic"
14 November 2019 - - A newly published study demonstrates clinical evidence for the effectiveness of a first-of-its-kind, FDA-cleared assay for the detection of the sexually transmitted bacterium ...
Merck's ERVEBO Ebola Zaire Vaccine Granted Conditional Approval in the European Union
14 November 2019 - - The European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus ...
MeMed receives EUR2.5m in non-dilutive funding from the European Innovation Council
14 November 2019 - MeMed Ltd, a company involved in host response-based diagnostic solutions, announced yesterday that it has received EUR2.5m in non-dilutive funding from the European Innovation Coun...
First Light Diagnostics adds new member to international clinical advisory board
14 November 2019 - First Light Diagnostics, a developer of breakthrough automated products for rapid, sensitive and cost-effective diagnosis of life-threatening, antibiotic-resistant infections, annou...